Cargando…
Detection of HER-2/neu, c-myc amplification and p53 inactivation by FISH in Egyptian patients with breast cancer
Breast cancer is a leading cause of cancer-related deaths in women worldwide. The clinical course of this disease is highly variable and clinicians continuously search for prognostic parameters that can accurately predict prognosis, and indicate a suitable adjuvant therapy for each patient. Amplific...
Autores principales: | Ismail, Manal F., Aly, Magdy Sayed, Khaled, Hussein M., Mohamed, Hanaa M. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
German Medical Science GMS Publishing House
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2716551/ https://www.ncbi.nlm.nih.gov/pubmed/19675743 http://dx.doi.org/10.3205/000062 |
Ejemplares similares
-
Her2/neu Protein Expression and Oncogene Amplification in Gastric Carcinoma with Clinico-Pathological Correlation in Egyptian Patients
por: Hadi, Ahmed Abdel, et al.
Publicado: (2016) -
HER-2/neu oncogene: what does amplification mean?
por: Pavy, J. J., et al.
Publicado: (1993) -
LED-FISH: Fluorescence microscopy based on light emitting diodes for the molecular analysis of Her-2/neu oncogene amplification
por: Lang, Dagmar S, et al.
Publicado: (2008) -
Anti-Her-2/neu antibody induces apoptosis in Her-2/neu overexpressing breast cancer cells independently from p53 status
por: Brodowicz, T, et al.
Publicado: (2001) -
TOPOIIα and HER-2/neu overexpression/amplification in Barrett’s oesophagus, dysplasia and adenocarcinoma
por: Rossi, Elisa, et al.
Publicado: (2010)